Dr. Martens (DRMTY)
| Bid | 1.09 |
| Market Cap | 524.75M |
| Revenue (ttm) | 877.1M |
| Net Income (ttm) | 69.2M |
| EPS (ttm) | 0.08 |
| PE Ratio (ttm) | 13.61 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 1.09 |
| Volume | 2,373 |
| Avg. Volume (20D) | 112 |
| Open | 1.04 |
| Previous Close | 1.04 |
| Day's Range | 0.78 - 1.09 |
| 52-Week Range | 0.78 - 2.24 |
| Beta | 0.07 |
About DRMTY
Dr. Martens plc designs, develops, procures, markets, sells, and distributes footwear in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. Its product segments include originals, fusion, kids, and casual, as well as accessories. The company offers its products under the Dr. Martens brand name. Dr. Martens plc was founded in 1945 and is based in London, the United Kingdom....
2 months ago · seekingalpha.com
Dr. Martens plc (DOCMF) Q3 2025 Sales/ Trading Statement Call TranscriptDr. Martens plc (OTCPK:DOCMF) Q3 2025 Sales/ Trading Statement Call January 27, 2025 4:00 AM ET Company Participants Ije Nwokorie - CEO Giles Wilson - CFO Conference Call Participants Kate Calvert - I...
2 months ago · proactiveinvestors.co.uk
Dr Martens flags ‘progress' as constant currency revenue growsDr Martens PLC has flagged “good progress” in its turnaround after revenue ticked up on a constant currency basis during the third quarter. Group revenue climbed by 3% to £267 million, aided by strong...
2 months ago · proactiveinvestors.co.uk
Dr Martens and Ryanair in focus on MondayUpdates from Dr Martens and Ryanair on Monday will kick off next week's proceedings.